New Research Reveals Diabetes Stigma in UK Media: Differing Portrayals of Type 1 and Type 2

The Escalating Diabetes Challenge in the United Kingdom

Diabetes has emerged as one of the most pressing public health issues in the UK, affecting millions and straining healthcare resources. According to recent estimates from Diabetes UK, more than 5.8 million people are living with diabetes in the UK, with around 4.6 million diagnosed cases. Type 2 diabetes accounts for approximately 90% of cases, primarily linked to insulin resistance often influenced by genetic, lifestyle, and environmental factors, while Type 1 diabetes, an autoimmune condition requiring lifelong insulin therapy, makes up the remaining 10%, typically diagnosed in childhood or young adulthood. The National Diabetes Audit reports over 284,000 people with Type 1 diabetes in England alone as of 2024-25, highlighting the scale of both conditions.

Beyond the physical toll, diabetes carries a heavy psychosocial burden, exacerbated by widespread stigma. This stigma manifests as blame, shame, and judgment, often rooted in misconceptions about the causes and management of the disease. A 2025 survey by Diabetes UK revealed that 86% of people with Type 1 diabetes and 75% with Type 2 have experienced judgment related to their condition, with over half missing healthcare appointments due to fear of stigma. Such experiences not only deter self-care but also contribute to poorer health outcomes, including delayed diagnoses and complications like cardiovascular disease and neuropathy.

The media plays a pivotal role in shaping public perceptions, often amplifying stereotypes through selective framing and language. Recent academic research from Cardiff University has shed light on how UK press coverage differentially portrays Type 1 and Type 2 diabetes, potentially fueling these stigmas.

Cardiff University's Groundbreaking Media Analysis

Led by Dr. Sara Vilar-Lluch and Professor Dawn Knight from the School of English, Communication and Philosophy at Cardiff University, a comprehensive study published in PLOS ONE on April 30, 2026, titled "Type 1 and Type 2 diabetes in the UK press: A diachronic corpus-based analysis," examined nearly 10,000 news articles from 2020 to 2024. This work utilized the Diabetes UK News Media Corpus, comprising 9,673 articles totaling almost 10 million words from the top 10 UK national newspapers, including The Guardian, The Times, and the Daily Mail.

The researchers employed advanced corpus linguistics tools like Sketch Engine to analyze collocates—words frequently appearing near "diabetes"—revealing patterns in discourse. This diachronic approach tracked changes over time, classifying language into themes such as preferred versus dispreferred terms, causes, management, and associations with other conditions. The study highlights how media narratives can perpetuate misunderstandings and stigma by foregrounding individual responsibility while neglecting social determinants of health (SDH) like poverty, access to healthy food, and socioeconomic inequalities.

Methodology: Unpacking Media Language Through Data

The study's rigorous methodology involved compiling sub-corpora for Type 1 diabetes (T1D) and Type 2 diabetes (T2D) using targeted searches like “type 1 diabetes.” Articles were filtered for UK relevance, duplicates removed via Python scripts, and analyzed for grammatical structures such as pre-modifiers, verbs, and co-occurrences. Collocates were ranked by logDice scores and thematically grouped, allowing for quantitative insights into qualitative discourse trends.

Key structures examined included nouns modifying "diabetes" (e.g., 'childhood' for T1D), verbs with diabetes as subject/object (e.g., 'manage diabetes'), and phrases like 'living with diabetes.' This revealed evolving language use aligned partially with Diabetes UK communication guidelines, which advocate person-first terms like 'person with diabetes' over 'diabetic' to reduce dehumanization.

Distinct Portrayals: Type 1 Diabetes in the Spotlight

Type 1 diabetes coverage leans heavily on a medical discourse, portraying it as an autoimmune condition with unknown causes often tied to genetic, viral, or environmental triggers. Terms like 'insulin-dependent' and associations with other autoimmune diseases (e.g., rheumatoid arthritis, multiple sclerosis) dominate, emphasizing biological inevitability rather than lifestyle fault. However, 43.57% of T1D articles refer to diabetes generally without specifying the type, risking confusion, and dispreferred language like 'sufferer' or 'patient' persists, albeit declining slowly.

This framing mitigates moral blame but individualizes management responsibility, implying personal failure if control falters. Coverage remains lower than T2D, with no sharp spikes, possibly due to fewer public health campaigns targeting T1D.

Type 2 Diabetes: Lifestyle Blame and Rising Coverage

In contrast, Type 2 diabetes garners significantly more attention, with coverage surging in 2023-2024 amid rising diagnoses. The dominant free will discourse links T2D to modifiable factors like diet, physical inactivity, and obesity, often framed as an 'epidemic' preventable through personal choices. Collocates such as 'obesity,' 'uncontrolled,' and 'undiagnosed' reinforce stereotypes of irresponsibility, while verbs like 'rise' and 'control' underscore urgency and individual agency.

Although medical management (e.g., medication) is increasingly noted, omission of SDH—such as food insecurity or low-income barriers to exercise—perpetuates blame. Associations with cardiovascular disease, cancer, and depression further stigmatize T2D as a consequence of poor habits.

Language Matters: From Guidelines to Headlines

The study notes gradual adoption of guideline-recommended language, like 'person living with diabetes' and 'managing diabetes,' but dispreferred terms show minimal decline. For T1D, medicalized nouns heighten 'patient' usage; for T2D, lifestyle emphasis sustains blame-laden narratives. General references (no type specified) in 43% of T1D and similar for T2D foster conflation, where T1D is misperceived as lifestyle-related. For more on the full study, see the PLOS ONE publication.

Real-World Stigma: Voices from Diabetes UK Survey

Complementing the media analysis, Diabetes UK's 2025 national survey of over 1,600 adults underscores lived experiences: 86% of Type 1 and 75% of Type 2 respondents faced blame, with 50% skipping appointments. Media amplifies this, as 55% of Type 1 respondents noted public assumptions of poor self-care necessitating insulin. The 'Strike Out Stigma' campaign calls for attitude shifts to improve confidence and care access.

Consequences: Health, Mental Well-Being, and Society

Stigma leads to internalized shame, reduced self-efficacy, and avoidance of healthy behaviors. For Type 2, blame discourages diagnosis; for Type 1, management fatigue intensifies. Economically, poor control costs the NHS billions annually in complications. Culturally, UK media's individual focus ignores SDH disparities, disproportionately affecting deprived communities where Type 2 prevalence is higher.

• Delayed care increases hospitalization risks.
• Mental health impacts: anxiety, depression rates double.
• Social exclusion: workplace discrimination reported by 40%.

Stakeholder Perspectives: Experts Weigh In

Dr. Vilar-Lluch emphasizes, "Omitting social determinants foregrounds individual agency, overlooking inequalities." Diabetes UK advocates clearer type distinctions and holistic reporting. Healthcare professionals note media-driven myths hinder patient education. For deeper insights, explore Diabetes UK's stigma resources.

Solutions: Towards Stigma-Free Media and Communication

Recommendations include strict guideline adherence, explicit type references, and SDH integration. Journalists should avoid causal juxtapositions (e.g., diabetes-obesity). Training via Diabetes UK partnerships could transform coverage. Broader efforts: public campaigns, policy mandating balanced reporting.

Photo by diabetesmagazijn.nl on Unsplash

Future Outlook: Research, Policy, and Hope

Ongoing studies at Cardiff and Diabetes UK aim to monitor trends post-2024. With prevalence projected to rise, addressing media stigma is urgent. Positive shifts in language offer hope, but sustained action is needed for equitable health narratives.